Fingerprint
Dive into the research topics of 'Does pegylated interferon α-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Does pegylated interferon α-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?
John M. Kirkwood, Hussein A. Tawbi, Ahmad A. Tarhini, Stergios J. Moschos
Research output: Contribution to journal › Comment/debate › peer-review